VeriChip Corporation [[CHIP]], which has developed a system to identify people who enter an emergency room without being able to communicate, announced that it has entered into a strategic partnership with the Diabetes Research Institute to combine efforts on the further development of its glucose-sensing radio frequency identification microchip.
VeriChip and DRI intend to recreate a prospective, randomized, comparative clinical study that will seek to address the lack of appropriate, concise, and up-to-date patient health information available to both practitioners caring for diabetic patients and the patients themselves through utilization of the company’s interoperable personal health record, Health Link, system.
No comments:
Post a Comment